Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Nuclear Medicine/Radiopharmaceuticals Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Nuclear Medicine/Radiopharmaceuticals Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications, 2020-2028 (USD Billion)
1.2.4. Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nuclear Medicine/Radiopharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine/Radiopharmaceuticals Market Dynamics
3.1. Nuclear Medicine/Radiopharmaceuticals Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of target conditions
3.1.1.2. Development of alpha-radioimmunotherapy-based targeted cancer treatments
3.1.2. Market Challenges
3.1.2.1. Short half-life of radiopharmaceuticals
3.1.2.2. Hospital budget cuts and high equipment costs
3.1.3. Market Opportunities
3.1.3.1. Use of radiopharmaceuticals in neurological applications
3.1.3.2. Increasing investment in the R&D activities
Chapter 4. Global Nuclear Medicine/Radiopharmaceuticals Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Nuclear Medicine/Radiopharmaceuticals Market, by Type
6.1. Market Snapshot
6.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Type, Performance - Potential Analysis
6.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Nuclear Medicine
6.4.2. Therapeutic Nuclear Medicine
6.4.3. Brachytherapy Isotopes
Chapter 7. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications
7.1. Market Snapshot
7.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Applications, Performance - Potential Analysis
7.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Applications 2018-2028 (USD Billion)
7.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. SPECT Applications
7.4.2. PET Applications
7.4.3. Therapeutic Applications
Chapter 8. Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment
8.1. Market Snapshot
8.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment, Performance - Potential Analysis
8.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume Assessment 2018-2028 (USD Billion)
8.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
8.4.1. Diagnostic Procedures
8.4.2. Therapeutic Procedures
Chapter 9. Global Nuclear Medicine/Radiopharmaceuticals Market, Regional Analysis
9.1. Nuclear Medicine/Radiopharmaceuticals Market, Regional Market Snapshot
9.2. North America Nuclear Medicine/Radiopharmaceuticals Market
9.2.1. U.S. Nuclear Medicine/Radiopharmaceuticals Market
9.2.1.1. Type estimates & forecasts, 2018-2028
9.2.1.2. Applications estimates & forecasts, 2018-2028
9.2.1.3. Procedural Volume Assessment estimates & forecasts, 2018-2028
9.2.2. Canada Nuclear Medicine/Radiopharmaceuticals Market
9.3. Europe Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.3.1. U.K. Nuclear Medicine/Radiopharmaceuticals Market
9.3.2. Germany Nuclear Medicine/Radiopharmaceuticals Market
9.3.3. France Nuclear Medicine/Radiopharmaceuticals Market
9.3.4. Spain Nuclear Medicine/Radiopharmaceuticals Market
9.3.5. Italy Nuclear Medicine/Radiopharmaceuticals Market
9.3.6. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market
9.4. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.4.1. China Nuclear Medicine/Radiopharmaceuticals Market
9.4.2. India Nuclear Medicine/Radiopharmaceuticals Market
9.4.3. Japan Nuclear Medicine/Radiopharmaceuticals Market
9.4.4. Australia Nuclear Medicine/Radiopharmaceuticals Market
9.4.5. South Korea Nuclear Medicine/Radiopharmaceuticals Market
9.4.6. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market
9.5. Latin America Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.5.1. Brazil Nuclear Medicine/Radiopharmaceuticals Market
9.5.2. Mexico Nuclear Medicine/Radiopharmaceuticals Market
9.6. Rest of The World Nuclear Medicine/Radiopharmaceuticals Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Cardinal Health Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GE Healthcare Company
10.2.3. Curium SAS
10.2.4. Lantheus Medical Imaging Inc.
10.2.5. Bayer AG
10.2.6. Bracco Imaging Inc.
10.2.7. Eczacybay-Monrol Nuclear Products
10.2.8. Nordion Inc.
10.2.9. Advanced Accelerator Applications
10.2.10. NTP Radioisotopes SOC Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption